美国糖尿病协会2025版糖尿病诊疗标准更新要点解读

董晓颖; 尹经霞; 李令; 余丽; 蒲丹岚; 廖涌

doi:10.13406/j.cnki.cyxb.003750

重庆医科大学学报 ›› 2025, Vol. 50 ›› Issue (05) : 565 -573. DOI: 10.13406/j.cnki.cyxb.003750

内分泌调控与代谢疾病

美国糖尿病协会2025版糖尿病诊疗标准更新要点解读

董晓颖 ¹ ,
尹经霞 ¹ ,
李令 ¹ ,
余丽 ¹ ,
蒲丹岚 ² ,
廖涌 ¹

作者信息 +

Interpretation of updated key points in the American Diabetes Association’s 2025 Standards of Care in Diabetes

Xiaoying Dong ¹ ,
Jingxia Yin ¹ ,
Ling Li ¹ ,
Li Yu ¹ ,
Danlan Pu ² ,
Yong Liao ¹

Author information +

文章历史 +

PDF (2223K)

摘要

美国糖尿病协会（American Diabetes Association，ADA）多年来积极致力于糖尿病诊疗及日常照护标准的制定与推广，自1989年以来每年更新一版糖尿病诊疗标准，已成为糖尿病领域最权威的指南之一，得到了各国的认可和采纳。2024年12月10日，2025版糖尿病诊疗标准发布，融合了与糖尿病及其并发症和合并症相关的最新循证医学证据，旨在为临床医师、患者及家属、研究人员等提供其诊断、治疗、管理方面的指导意见。本文将择其重要更新要点进行解读。

Abstract

Over the years，the American Diabetes Association（ADA） has been actively committed to the development and promotion of standards for the diagnosis，treatment，and daily care of diabetes. Since 1989，it has updated the diabetes diagnosis and treatment standards every year，which have become one of the most authoritative guidelines in diabetes and have been recognized and adopted by various countries. On December 10，2024，the 2025 Standards of Care in Diabetes were released，incorporating the latest evidence-based medicine content related to diabetes and its complications and comorbidities. It aims to provide guidance on the diagnosis，treatment，and management of the condition for clinicians，patients and their families，and researchers. This article interprets the major updates from the Standards.